Druker (born April 30, 1955) is a physician-scientist at Oregon Health & Science University, in Portland, Oregon.
He is the director of OHSU's Knight Cancer Institute, Jeld-Wen Chair of Leukemia Research, and professor of medicine.
In 2009, he won the Lasker-DeBakey Clinical Medical Research Award and the Meyenburg Award for his influential work in the development of Imatinib (or STI571), commonly known as Gleevec, for the treatment of chronic myeloid leukemia (CML).
He has been called "Oregon's best-known scientist".